1. StarD13 3’-untranslated region functions as a ceRNA for TP53INP1 in prohibiting migration and invasion of breast cancer cells by regulating miR-125b activity
    Lufeng Zheng et al, 2017, European Journal of Cell Biology CrossRef
  2. Displacement of Bax by BMF Mediates STARD13 3′UTR-Induced Breast Cancer Cells Apoptosis in an miRNA-Depedent Manner
    Xinwei Guo et al, 2017, Mol. Pharmaceutics CrossRef
  3. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2 ) in ErbB2 (Neu ) oncogene induced mouse mammary tumors
    Pratima Basak et al, 2017, Genes Chromosomes Cancer CrossRef
  4. Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells
    Marwa Al Hassan et al, 2018, Analytical Cellular Pathology CrossRef
  5. Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer
    Knut M. Wittkowski et al, 2018, PLoS ONE CrossRef
  6. RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3'UTR with miRNAs.
    Ruixi Hu et al, 2018, Cell Prolif CrossRef
  7. Gap Junctions and Wnt Signaling in the Mammary Gland: a Cross-Talk?
    Sabreen F. Fostok et al, 2018, J Mammary Gland Biol Neoplasia CrossRef
  8. Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice
    Liang Chi et al, 2018, Arch Toxicol CrossRef
  9. Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13
    Lin Chen et al, 2019, Cell Mol Biol Lett CrossRef
  10. Connexin 43 Loss Triggers Cell Cycle Entry and Invasion in Non-Neoplastic Breast Epithelium: A Role for Noncanonical Wnt Signaling
    Sabreen Fostok et al, 2019, Cancers CrossRef
  11. RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells
    Oula El Atat et al, 2019, Cells CrossRef
  12. The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell–cell adhesion
    Elisa Vitiello et al, 2014, Nat Commun CrossRef
  13. Evaluation of miR-720 prognostic significance in patients with colorectal cancer
    Xu Wang et al, 2015, Tumor Biol. CrossRef
  14. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance
    Daphna Mokady et al, 2015, Drug Resistance Updates CrossRef
  15. Under hypoxia conditions contactin-1 regulates the migration of Mkn45 cells through the RhoA pathway
    G. Yang et al, 2015, Mol Biol CrossRef
  16. Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight
    Leonardo Osti et al, 2015, BMC Musculoskelet Disord CrossRef
  17. Hypoxia and EGF Stimulation Regulate VEGF Expression in Human Glioblastoma Multiforme (GBM) Cells by Differential Regulation of the PI3K/Rho-GTPase and MAPK Pathways
    Samer Nicolas et al, 2019, Cells CrossRef
  18. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
    Houssam Al-Koussa et al, 2019, Int J Mol Sci CrossRef
  19. StarD13: a potential star target for tumor therapeutics
    Leila Jaafar et al, 2020, Human Cell CrossRef
  20. Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients
    Qiang Tan et al, 2016, Oncotarget CrossRef
  21. DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway
    Zheng Yang et al, 2018, Oncol Lett CrossRef
  22. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation
    Maria Al Haddad et al, 2020, Cell Commun Signal CrossRef
  23. Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses
    Brock Humphries et al, 2020, Cells CrossRef
  24. StarD13 differentially regulates migration and invasion in prostate cancer cells
    Leila Jaafar et al, 2021, Human Cell CrossRef
  25. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA
    Nour El-Mais et al, 2021, J Ovarian Res CrossRef
  26. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
    Juliette Coignard et al, 2021, Nat Commun CrossRef
  27. Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways
    Arsalan Amirfallah et al, 2021, PLoS ONE CrossRef
  28. StarD13 negatively regulates invadopodia formation and invasion in high-grade serous (HGS) ovarian adenocarcinoma cells by inhibiting Cdc42
    Sandra Abdellatef et al, 2021, European Journal of Cell Biology CrossRef
  29. Fixing the GAP: the role of RhoGAPs in cancer
    Gabriel Kreider-Letterman et al, 2022, European Journal of Cell Biology CrossRef
  30. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
    Rasoul Abdollahzadeh et al, 2019, J Cell Physiol CrossRef
  31. Two-sample t α -test for testing hypotheses in small-sample experiments
    Yuan-De Tan, 2022 CrossRef
  32. Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis
    Xu Zhang et al, 2022, Biol Proced Online CrossRef
  33. Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?
    Huan Xiao et al, 2023, European Journal of Medicinal Chemistry CrossRef
  34. Human Milk-Derived Levels of let-7g-5p May Serve as a Diagnostic and Prognostic Marker of Low Milk Supply in Breastfeeding Women
    Steven D. Hicks et al, 2023, Nutrients CrossRef
  35. Loss of STARD13 contributes to aggressive phenotype transformation and poor prognosis in papillary thyroid carcinoma
    Chuimian Zeng et al, 2023, Endocrine CrossRef
  36. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine
    Roberto Piergentili et al, 2024, ncRNA CrossRef